NCT04737018

Brief Summary

In about 40 percent of cases, after a stroke, neuromotor impairment leads to activity limitations and the development of chronic functional disorders, which have a significant impact on patient autonomy. In the early subacute phase, motor deficit in foot lifters is one of the factors limiting standing posture and ambulation, which is ultimately difficult to rehabilitate due to the lack of available techniques for obtaining early onset of useful active voluntary contraction. The use of muscular focal vibration therapy, applied to relaxed muscle, may be of interest due to the portability and availability of the system and the neuromotor benefits demonstrated in healthy subjects and in acute and chronic post-stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started May 2021

Typical duration for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 3, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

May 14, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

December 27, 2023

Status Verified

December 1, 2023

Enrollment Period

2.4 years

First QC Date

January 28, 2021

Last Update Submit

December 26, 2023

Conditions

Keywords

muscle vibration protocolanterior tibia musclehemiplegic patient

Outcome Measures

Primary Outcomes (1)

  • score of Fugl Meyer Assessment (lower limbs)

    score from 0 to 34 Stroke-specific performance-based disability index that quantitatively assesses analytical motor skills in the lower limb.

    day 30

Secondary Outcomes (6)

  • score of Fugl Meyer Assessment (lower limbs)

    day 0, day 15, day 30 and month 2

  • score of Medical Research Concil

    day 0, day 15, day 30 and month 2

  • assess functional walking ability

    day 0, day 15, day 30 and month 2

  • score of postural assessment scale for stroke

    day 0, day 15, day 30 and month 2

  • analysis of static equilibrium

    day 0, day 15, day 30 and month 2

  • +1 more secondary outcomes

Study Arms (2)

vibration program

EXPERIMENTAL

a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm

Other: Fugl-Meyer Assessment (FMA)Other: Medical Research Concil (MRC)Other: 2 Minute Walk Test (2MWT)Other: Timed Up & Go TestOther: Modified Ashworth ScaleOther: Postural Assessment Scale for StrokeDevice: posturographic recordingOther: vibration program

sham program

SHAM COMPARATOR

a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.

Other: Fugl-Meyer Assessment (FMA)Other: Medical Research Concil (MRC)Other: 2 Minute Walk Test (2MWT)Other: Timed Up & Go TestOther: Modified Ashworth ScaleOther: Postural Assessment Scale for StrokeDevice: posturographic recordingOther: sham program

Interventions

assessment of motor skills : measurement of the intensity of reflexes, as well as an assessment of voluntary movements and motor coordination Score from 0 to 34

sham programvibration program

evaluation of muscular strength score from 0 to 5

sham programvibration program

Assess functional walking and aerobic abilities

sham programvibration program

measures the time it takes to get up from a chair, walk 10 feet, turn around, return to the seat and sit down

sham programvibration program

score from 0 to 4 evaluation of spasticity

sham programvibration program

score from 0 to 36 measures the patient's ability to maintain stable postures and balance in changes of position

sham programvibration program

analysis of static equilibrium parameters and positional measurement of the center of gravity on the Winposturo platform

sham programvibration program

a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm

vibration program

a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.

sham program

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having had a stroke (with or without previous stroke) and being in the early subacute phase (between 14 days and 3 months of stroke).
  • Responsible for a motor deficit in the right or left lower limb.
  • No neurological history other than stroke.

You may not qualify if:

  • Multifocal stroke
  • Patient having received a botulinum toxin injection to the lower limb to be vibrated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Universitaire de Saint-Etienne

Saint-Etienne, 42055, France

Location

Le Clos Champirol - Service de Médecine Physique et de Réadaptation

Saint-Priest-en-Jarez, France

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Bruno FERNANDEZ, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2021

First Posted

February 3, 2021

Study Start

May 14, 2021

Primary Completion

September 29, 2023

Study Completion

December 15, 2023

Last Updated

December 27, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations